Loading…
Alphatec Holdings, Inc. is projected to rise to $10.22 by 2027, a +7% move from its current price of $9.52. ATEC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $9.23 | $9.52 | $9.83 | +0.05% |
| Aug 3 | $9.11 | $9.53 | $9.97 | +0.10% |
| Aug 4 | $9.02 | $9.53 | $10.07 | +0.16% |
| Aug 5 | $8.95 | $9.54 | $10.17 | +0.21% |
| Aug 6 | $8.89 | $9.55 | $10.25 | +0.26% |
| Aug 7 | $8.83 | $9.55 | $10.32 | +0.32% |
| Aug 8 | $8.78 | $9.56 | $10.39 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.78 | $9.56 | $10.39 | +0.37% |
| Week 2 | $8.51 | $9.59 | $10.80 | +0.74% |
| Week 3 | $8.32 | $9.63 | $11.13 | +1.11% |
| Week 4 | $8.17 | $9.66 | $11.43 | +1.48% |
| Week 5 | $8.03 | $9.70 | $11.70 | +1.85% |
| Week 6 | $7.92 | $9.73 | $11.96 | +2.23% |
| Week 7 | $7.82 | $9.77 | $12.20 | +2.60% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alphatec Holdings, Inc. is a medical technology company that designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications.
The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
Alphatec Holdings, Inc. trades under the symbol ATEC and is categorized in Healthcare. Its current price is $9.32 with a market capitalization of $1.43B and a market rank of 2199. The stock sits in a 30-day trading range between $7.57 and $11.48.
The longer-term price outlook, based on year-by-year forecasts, shows a path from today’s level toward higher prices in the coming years, with bullish momentum indicated from 2030 onward.
A major floor 26.6% below — a decisive break under it would weaken the trend.
The nearest floor, 15.3% below — buyers have tended to step in here.
Price is pressing into resistance (2.3% away) — a breakout level to watch.
A major ceiling 23.4% above — clearing it would confirm fresh momentum.
Key ATEC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATEC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.36 | Buy | $9.34 | Buy |
| MA 10 | $8.79 | Buy | $9.11 | Buy |
| MA 20 | $9.02 | Buy | $8.97 | Buy |
| MA 50 | $8.59 | Buy | $9.02 | Buy |
| MA 100 | $9.56 | Sell | $10.02 | Sell |
| MA 200 | $13.56 | Sell | $11.51 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.94 | Neutral |
| Stoch RSI (14) | 89.09 | Sell |
| CCI (20) | 67.20 | Neutral |
| Williams %R (14) | -8.75 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 5.31 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 91.25 | Sell |
| TRIX (15) | 0.10 | Buy |
| Awesome (5,34) | 0.47 | Buy |
| Ultimate (7,14,28) | 74.14 | Sell |
| Momentum (10) | 0.98 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 9.93 | Sell |
| ADX (14) | 15.16 | Neutral |
| ATR (14) | 0.26 | Info |
The 30-day technical picture shows a neutral posture with an RSI of 50. The 50-day simple moving average is $8.46, while the 200-day simple moving average is $13.64. Immediate support is identified at $8.06 and resistance at $9.74. Over the next 30 days, the price could oscillate within the range of $7.57 to $11.48, reflecting a balanced near-term outlook.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.99 | $9.52 | $12.12 | 0% | Neutral | |
| $8.03 | $10.22 | $13.82 | +7% | Neutral | |
| $8.57 | $11.29 | $15.93 | +19% | Neutral | |
| $9.18 | $12.42 | $18.13 | +30% | Bullish | |
| $10.02 | $13.90 | $20.85 | +46% | Bullish | |
| $12.64 | $17.93 | $27.55 | +88% | Bullish | |
| $13.98 | $20.25 | $31.80 | +113% | Bullish | |
| $14.52 | $21.45 | $34.35 | +125% | Bullish | |
| $15.20 | $22.88 | $37.30 | +140% | Bullish | |
| $14.28 | $21.88 | $36.26 | +130% | Bullish | |
| $23.91 | $39.79 | $70.64 | +318% | Bullish | |
| $35.32 | $67.95 | $133.22 | +614% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $6.99 | $9.52 | $11.45 | +0.00% |
| September 2026 | $8.11 | $9.64 | $11.82 | +1.24% |
| October 2026 | $8.33 | $9.99 | $12.40 | +3.61% |
| November 2026 | $8.19 | $9.88 | $12.39 | -1.04% |
| December 2026 | $7.90 | $9.58 | $12.12 | -3.04% |
Click any year to see its month-by-month ATEC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ATEC price prediction for 2026 points to an average of $9.52 (low $6.99, high $12.12) — a potential gain of 0% on today's $9.52. Price action looks broadly range-bound.
In 2027, ATEC is projected to trade between $8.03 and $13.82, averaging $10.22 — a potential gain of +7% from today's $9.52. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
Alphatec Holdings, Inc.'s 2028 outlook centres on $11.29, within a $8.57 to $15.93 range. That is up +10% on the projected 2027 average. That marks a +19% change versus current levels. Price action looks broadly range-bound.
By 2029, ATEC could reach as high as $18.13, with a base case around $12.42 and support toward $9.18 — roughly +30% from $9.52. Buyers look set to stay in control over this stretch.
Expect ATEC to range from $10.02 to $20.85 through 2030. The $13.90 average target implies a +46% move from current prices. That is up +12% on the projected 2029 average. Momentum favours further upside here.
The ATEC price prediction for 2031 points to an average of $17.93 (low $12.64, high $27.55) — a potential gain of +88% on today's $9.52. Buyers look set to stay in control over this stretch.
In 2032, ATEC is projected to trade between $13.98 and $31.80, averaging $20.25 — a potential gain of +113% from today's $9.52. That is up +13% on the projected 2031 average. Momentum favours further upside here.
Alphatec Holdings, Inc.'s 2033 outlook centres on $21.45, within a $14.52 to $34.35 range. That is up +6% on the projected 2032 average. That marks a +125% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ATEC could reach as high as $37.30, with a base case around $22.88 and support toward $15.20 — roughly +140% from $9.52. Momentum favours further upside here.
Expect ATEC to range from $14.28 to $36.26 through 2035. The $21.88 average target implies a +130% move from current prices. That is -4% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The ATEC price prediction for 2040 points to an average of $39.79 (low $23.91, high $70.64) — a potential gain of +318% on today's $9.52. Momentum favours further upside here.
In 2050, ATEC is projected to trade between $35.32 and $133.22, averaging $67.95 — a potential gain of +614% from today's $9.52. That is up +71% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ATEC today (≈ 105.042017 ATEC) could be worth
$7,137.43
+$6,137.43 (+614%) by 2050 · US Dollar
Based on the average projected ATEC price of $67.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATECwould be worth at today's price.
$1,000 invested in ATEC on Jul 31, 2025 (≈ 94.517959 ATEC) would be worth
$899.81
-$100.19 (-10.0%) today · 0.90× · US Dollar
Based on a ATEC entry price of $10.58 vs. today's $9.52.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.26 | $1,152.54 | +15.3% |
| 1 month ago | $8.86 | $1,074.49 | +7.4% |
| 3 months ago | $10.43 | $912.75 | -8.7% |
| 6 months ago | $14.49 | $657 | -34.3% |
| 1 year ago | $10.58 | $899.81 | -10.0% |
| All time (5.0y) ago | $14.88 | $639.78 | -36.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATEC forecast.
Our base-case forecast reaches $19.00 around 2032.
Implied market cap at $19.00: $2.92B
The multi-year forecast shows a clear bullish trajectory starting in 2030. In 2026, the average price is forecast at $9.32 with a min of $6.99 and a max of $11.72 (ROI 0%). By 2030, the average rises to $11.84 with a max of $17.75, delivering a 27% ROI and a bullish sentiment.
The forecast continues to climb in 2040, with an average of $30.21 and a max of $53.54, implying a 224.2% ROI and a bullish stance. By 2050, the average is projected at $48.64 with a max of $95.17, representing a 421.9% ROI and bullish sentiment. The path includes intermediate years such as 2031 (avg $14.91, max $22.89, ROI 59.9%), 2032 (avg $16.86, max $26.45, ROI 80.9%), 2033 (avg $17.66, max $28.25, ROI 89.5%), 2034 (avg $18.46, max $30.05, ROI 98.1%), and 2035 (avg $17.54, max $29.02, ROI 88.2%).
These figures illustrate a rising, though not guaranteed, long-term trajectory with substantial upside potential and meaningful risk,” as with all forecasts.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $11.84 with a min of $8.54 and a max of $17.75, and a 27% ROI. The sentiment is bullish for that year.
The near term (2026-2029) shows modest gains with averages around $9.32 to $10.99 and ROIs from 0% to 17.9%. From 2030 onward, the forecast is bullish, with higher average prices and significant ROIs in later years (e.g., 2030 27%, 2040 224.2%, 2050 421.9%). These are estimates, not guarantees.
Yes. The 2031 max is $22.89 and the 2032 max is $26.45, indicating prices above $20 are possible within the forecast horizon.
The 2040 forecast shows an average price of $30.21, a max of $53.54, and a 224.2% ROI, with bullish sentiment.
The current price is $9.32 and the market capitalization is $1.43B, with a market rank of 2199.
Alphatec Holdings, Inc. Community Discussion
0Share your Alphatec Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.